Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of nicotinic receptor agonists and antagonists for neurological and psychiatric disorders. Its structure allows for selective binding and modification in drug design, enhancing bioavailability and target specificity. Commonly employed in research settings for creating analogs with potential cognitive-enhancing or neuroprotective effects.